BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.1850
-0.0190 (-9.31%)
At close: Mar 3, 2026, 4:00 PM EST
0.1848
-0.0002 (-0.11%)
After-hours: Mar 3, 2026, 7:17 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Pharmaceuticals
11.00M
250.00K429.00K5.20M10.63M
Pharmaceuticals Growth
-
-41.72%-91.75%-51.07%-
Total
11.00M
250.00K429.00K5.20M10.63M
Total Growth
-
-41.72%-91.75%-51.07%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States
11.00M
250.00K429.00K5.20M10.63M
United States Growth
-
-41.72%-91.75%-51.07%-
Total
11.00M
250.00K429.00K5.20M10.63M
Total Growth
-
-41.72%-91.75%-51.07%-
Source: S&P Global Market Intelligence.